Indian Bulk Drug Makers Trim Production In Face Of Rising Costs
This article was originally published in PharmAsia News
Executive Summary
Indian makers of bulk drugs are trimming production of several popular drugs in the face of high prices of the raw materials they use. Some producers of active pharmaceutical ingredients for antibiotics, paracetamon and anti-diarrhea drugs have cut their output as much as by half. The makers blame a short supply and a sharp increase in materials imported from China, a consequence, in part, of crude oil prices and an environmental crackdown in advance of the summer Olympics. (Click here for more